Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, California.
Monographs Programme, International Agency for Research on Cancer, Lyon, France.
Cancer Epidemiol Biomarkers Prev. 2020 Oct;29(10):1887-1903. doi: 10.1158/1055-9965.EPI-19-1346. Epub 2020 Mar 9.
The key characteristics (KC) of human carcinogens provide a uniform approach to evaluating mechanistic evidence in cancer hazard identification. Refinements to the approach were requested by organizations and individuals applying the KCs. We assembled an expert committee with knowledge of carcinogenesis and experience in applying the KCs in cancer hazard identification. We leveraged this expertise and examined the literature to more clearly describe each KC, identify current and emerging assays and biomarkers that can be used to measure them, and make recommendations for future assay development. We found that the KCs are clearly distinct from the Hallmarks of Cancer, that interrelationships among the KCs can be leveraged to strengthen the KC approach (and an understanding of environmental carcinogenesis), and that the KC approach is applicable to the systematic evaluation of a broad range of potential cancer hazards and We identified gaps in coverage of the KCs by current assays. Future efforts should expand the breadth, specificity, and sensitivity of validated assays and biomarkers that can measure the 10 KCs. Refinement of the KC approach will enhance and accelerate carcinogen identification, a first step in cancer prevention.
人类致癌物的关键特征(KC)为评估癌症危害识别中的机制证据提供了一种统一的方法。各组织和个人在应用 KC 时对该方法提出了改进要求。我们组建了一个专家委员会,该委员会的专家在致癌作用方面具有专业知识,并且在癌症危害识别中应用 KC 方面拥有丰富经验。我们利用这些专业知识和文献,更清楚地描述了每个 KC,确定了目前和新兴的可用于测量这些 KC 的检测和生物标志物,并为未来的检测开发提出了建议。我们发现,KC 与癌症的标志性特征明显不同,KC 之间的相互关系可以用来加强 KC 方法(以及对环境致癌作用的理解),并且 KC 方法适用于对广泛的潜在癌症危害进行系统评估。我们还发现,目前的检测方法对 KC 的覆盖范围存在差距。未来的工作应该扩大能够测量 10 个 KC 的已验证检测和生物标志物的广度、特异性和敏感性。对 KC 方法的改进将增强和加速致癌物的识别,这是癌症预防的第一步。